Target intelligence / Profile preview

Sodium- and chloride-dependent transporter

Molecular classification
Transporter, Symporter, Solute carrier, Secondary active transporter
01

Overview

Sodium- and chloride-dependent transporters comprise a large group of membrane proteins that rely on sodium and chloride gradients to drive the uptake or reuptake of various substrates, including neurotransmitters, amino acids, glucose, and ions, across cell membranes. These transporters include multiple gene families such as the SLC6 or NSS (neurotransmitter sodium symporter) family, responsible for neurotransmitter reuptake (e.g., serotonin, dopamine, glycine transporters), the SLC12 family (e.g., sodium-chloride cotransporter NCC, sodium-potassium-chloride cotransporters NKCC1/2), and the SLC5 family (e.g., sodium-glucose cotransporters SGLT1/2)[1][2][3][4][6]. They play roles in critical physiological processes: renal sodium reabsorption and blood pressure control (NCC, NKCC), CNS neurotransmitter regulation (SLC6 transporters), and glucose homeostasis (SGLTs). Dysfunction or pharmacologic inhibition of these transporters is implicated in diseases such as hypertension, neuropsychiatric disorders, and diabetes, and these proteins are major therapeutic targets for thiazide diuretics (NCC), SGLT2 inhibitors, and more[1][2][4].

Other names
SLC6 family transporterNSS transportersodium-chloride cotransportersodium-dependent cotransporterchloride-dependent transporter
02

Mechanism of action

Inhibition of sodium and/or chloride transport, Symport with substrate (e.g., glucose, amino acids, neurotransmitters), Indirect modulation of neurotransmitter levels

03

Biological functions

Neurotransmitter reuptakeAmino acid absorptionGlucose reabsorptionIon homeostasisSignal transduction
04

Disease associations

HypertensionGitelman syndromeSeSAME syndromePseudohypoaldosteronism type IINeuropsychiatric disordersDiabetes mellitusOther
05

Safety considerations

Electrolyte imbalance (hyponatremia, hypokalemia)HypotensionDehydrationHypoglycemia (SGLT2 inhibitor use)Off-target CNS effectsRisk of volume depletion
06

Interacting drugs

Thiazide diuretics (e.g., hydrochlorothiazide)

3 more in the full profile.

07

Biomarkers

Genetic mutations in SLC12A3 (NCC, related to Gitelman syndrome)SLC6A2 (norepinephrine transporter)SLC5A2 (SGLT2 for diabetes therapy selection)

Beyond the preview

Go deeper on Sodium- and chloride-dependent transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium- and chloride-dependent transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call